IRLAB Therapeutics AB
556931-4692ActiveDeveloping novel CNS drugs for Parkinson's disease using proprietary technology.
Biotechnology Companyirlab.se
Yleiskatsaus
- 1–4
- Työntekijät
- 5–10milj SEK
- Liikevaihto
- 2013
- Perustettu
Avainpäättäjät
Kristina Torfgård
Chief Executive Officer (CEO)
@irlab.se+46730XXXXXX
Clas Sonesson
Chief Scientific Officer (CSO)
@irlab.se
Carola Lemne
Chair of the Board
@irlab.se
Nicholas Waters
Executive Vice President and Head of R&D
@irlab.se
+4 lisää yhteystietoja Funnelfeedrissä
Kuvaus
IRLAB Therapeutics AB is a rapidly growing, publicly traded biotechnology company rooted in Nobel Prize-winning research. The organization specializes in discovering and developing novel treatments for Parkinson’s disease (PD) and other Central Nervous System (CNS) disorders. IRLAB utilizes its prop...